Skip to content

Efficacy of Preoperative Administration of Paracetamol-codeine on Pain Following Impacted Mandibular Third Molar Surgery

Efficacy of Preoperative Administration of Paracetamol-codeine on Pain Following Impacted Mandibular Third Molar Surgery: a Randomized, Split-mouth, Placebo-controller, Double-blind Clinical Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03049878
Enrollment
32
Registered
2017-02-10
Start date
2013-02-21
Completion date
2016-09-10
Last updated
2017-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Control Pain After Third Molar Surgery

Keywords

postoperative pain, paracetamol, codeine, tooth extractions, analgesia, premedication

Brief summary

Objectives: The aim of this study was to determine the effectiveness of preoperative administration of single-dose of paracetamol-codeine, in the relieving of acute post-operative pain after the surgical removal of an impacted mandibular third molar. Materials and Methods: The study cohort consisted of 32 Caucasian outpatients, giving a total of 64 bilateral symmetrical impacted mandibles. Patients were randomized in two experimental groups to receive a preoperative oral dose of paracetamol-codeine (analgesic group) or a placebo (placebo group) at the first and second surgeries. Study participants were asked to record pain intensity scores during the operation and the next 2 days, the time of the first request for rescue analgesic, and the total number of postoperative-supplement paracetamol-codeine tablets.

Interventions

preoperative administration

DRUGPlacebo Oral Tablet

preoperative administration

Sponsors

University of Roma La Sapienza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

A randomized, split-mouth, placebo-controlled, double-blind clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* absence of systemic pathologies (ASA class I); * non-smoker; * not pregnant or lactating; * good oral hygiene; * no drug consumption for 10 days before the operation; * bilateral impacted mandibular third molars with comparable position, depth and inclination; * presence of the first and second molars; * absence of painful symptoms and associated inflammatory or osteolytic pathologies in a radiographic examination; * extraction difficulty index of \>7 according to Pederson's scale and a degree of IV (complex procedures) on a modified version of Parant's scale.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) during the operative day.All study participants were asked to record the pain intensity score at 1:00 pm during the operative dayThe primary outcome of the study was the post-operative pain. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 (no pain) to 10 (maximum pain)
Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) during the 2th day after surgery.All study participants were asked to record the pain intensity score at 8:00 am during the 2th day after surgeryThe primary outcome of the study was the post-operative pain. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 (no pain) to 10 (maximum pain)
Pain measurement assessed with the Numerical Rating Scale-11 (NRS-11) during the 3th day after surgery.All study participants were asked to record the pain intensity score at 8:00 am during the 3th day after surgeryThe primary outcome of the study was the post-operative pain. Before surgery, patients were instructed to complete the Numerical Rating Scale-11 (NRS-11), which consisted of an interval scale ranging from 0 (no pain) to 10 (maximum pain)

Other

MeasureTime frameDescription
Number of patients using rescue therapyNumber of patients using rescue therapy on the same day from the end of the surgery and during 2 days after operative daysNumber of patients using rescue therapy during 3 days after surgery
Time of analgesic medicationTime elapsed from the end of surgery until the first intake of analgesic medication on the same day of the surgeryTime elapsed from the end of surgery until the first intake of analgesic medication (minutes)
Number of paracetamol-codeine tabletsNumber of paracetamol-codeine tablets taken by the patients during the 3 days after surgeryTotal number of paracetamol-codeine tablets with the same formulation taken by the patient in relation to the pain symptoms

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026